Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia (Q39712243)

14 September 2017

title

Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia (English)

1 reference

14 September 2017

1 reference

14

H Hasle

1 reference

14 September 2017

A Yoshimi

1

1 reference

14 September 2017

P Bader

2

1 reference

14 September 2017

S Matthes-Martin

3

1 reference

14 September 2017

J Starý

4

1 reference

14 September 2017

P Sedlacek

5

1 reference

14 September 2017

U Duffner

6

1 reference

14 September 2017

T Klingebiel

7

1 reference

14 September 2017

D Dilloo

8

1 reference

14 September 2017

W Holter

9

1 reference

14 September 2017

F Zintl

10

1 reference

14 September 2017

B Kremens

11

1 reference

14 September 2017

K-W Sykora

12

1 reference

14 September 2017

C Urban

13

1 reference

14 September 2017

E Korthof

15

1 reference

14 September 2017

T Révész

16

1 reference

14 September 2017

A Fischer

17

1 reference

14 September 2017

P Nöllke

18

1 reference

14 September 2017

F Locatelli

19

1 reference

14 September 2017

C M Niemeyer

20

1 reference

14 September 2017

European Working Group of MDS in Childhood (EWOG-MDS)

21

1 reference

14 September 2017

publication date

1 June 2005

1 reference

14 September 2017

1 reference

14 September 2017

volume

19

1 reference

14 September 2017

issue

6

1 reference

14 September 2017

page(s)

971-977

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403721

14 September 2017

exact match

0 references

cites work

A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

RAS mutations and clonality analysis in children with juvenile myelomonocytic leukemia (JMML)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Allogeneic hematopoietic stem cell transplantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on the criteria of the International JMML Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Allogeneic bone marrow transplantation for juvenile myelomonocytic leukaemia: a single centre experience and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Extramedullary relapse despite graft-versus-leukemia effect after bone marrow transplantation in a girl with juvenile myelomonocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Juvenile myelomonocytic leukemia relapsing after allogeneic bone marrow transplantation successfully treated with interferon-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Adjuvant interleukin-2 therapy for patients refractory to donor lymphocyte infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Transient hematologic and clinical effect of E21R in a child with end-stage juvenile myelomonocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Successful treatment of juvenile myelomonocytic leukemia relapsing after stem cell transplantation using donor lymphocyte infusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Successful treatment of JMML relapsed after unrelated allogeneic transplant with cytoreduction followed by DLI and interferon-alpha: evidence for a graft-versus-leukemia effect in non-monosomy-7 JMML

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Chemotherapy and donor leukocyte infusions for relapsed juvenile myelomonocytic leukemia (JMML)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for chimerism testing in different clinical-biological situations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Prediction and reversion of post-transplant relapse in patients with chronic myeloid leukemia using mixed chimerism and residual disease detection and adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Monitoring of residual disease and guided donor leucocyte infusion after allogeneic bone marrow transplantation by chimaerism analysis with short tandem repeats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Graft-versus-leukemia is sufficient to induce remission in juvenile myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Haemopoietic cell transplantation in children with juvenile myelomonocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403721

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403721

1 reference

14 September 2017

1 reference